TickerFacts.

Karyopharm Therapeutics Inc. (KPTI): Total Liabilities

Annual figures by period end, from SEC filings.

$401.34M
As of 2025-12-31
$441.49M
As of 2026-06-30
+2.3%
3-year compound annual growth
+8.9%
5-year compound annual growth
+37.1%
10-year compound annual growth
2013-12-31: $3.29M2014-12-31: $13.54M2015-12-31: $17.08M2016-12-31: $18.14M2017-12-31: $50.83M2018-12-31: $158.02M2019-12-31: $245.19M2020-12-31: $262.50M2021-12-31: $384.98M2022-12-31: $374.83M2023-12-31: $376.64M2024-12-31: $350.44M2025-12-31: $401.34M$401.34M
2013-12-31 Total Liabilities (USD) 2025-12-31
Period endedTotal LiabilitiesChange YoYSource filing
2025-12-31$401.34M+14.5%2026-02-13, Balance as of period end
2024-12-31$350.44M-7.0%2026-02-13, Balance as of period end
2023-12-31$376.64M+0.5%2025-02-19, Balance as of period end
2022-12-31$374.83M-2.6%2024-02-29, Balance as of period end
2021-12-31$384.98M+46.7%2023-02-17, Balance as of period end
2020-12-31$262.50M+7.1%2022-03-01, Balance as of period end
2019-12-31$245.19M+55.2%2021-02-24, Balance as of period end
2018-12-31$158.02M+210.9%2020-02-26, Balance as of period end
2017-12-31$50.83M+180.2%2019-02-28, Balance as of period end
2016-12-31$18.14M+6.2%2018-03-15, Balance as of period end
2015-12-31$17.08M+26.1%2017-03-16, Balance as of period end
2014-12-31$13.54M+311.4%2016-03-15, Balance as of period end
2013-12-31$3.29Mn/a2015-03-13, Balance as of period end

Total Liabilities at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedTotal LiabilitiesChange YoY
Karyopharm Therapeutics Inc. (KPTI)2025-12-31$401.34M+14.5%
Elite Pharmaceuticals Inc (ELTP)2026-03-31$39.41M-8.1%
Macrogenics Inc (MGNX)2025-12-31$201.25M+38.2%
Heron Therapeutics, Inc. (HRTX)2025-12-31$241.54M-9.5%
Liquidia Corp (LQDA)2025-12-31$283.19M+87.6%
Lifecore Biomedical, Inc. (LFCR)2025-05-25$191.91M-4.1%
Xencor Inc (XNCR)2025-12-31$239.91M-13.7%
Syndax Pharmaceuticals Inc (SNDX)2025-12-31$465.08M+6.5%
Phathom Pharmaceuticals, Inc. (PHAT)2025-12-31$697.32M+10.4%

Compare KPTI, ELTP, MGNX, HRTX side by side · Screen every company in Pharmaceutical Preparations ↗